# CDK7 inhibitor THZ1 enhances antiPD-1 therapy efficacy via the p38α/MYC/PD-L1 signaling in non-small cell lung cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cdk7-inhibitor-thz1-enhances-antipd-1-therapy-efficacy-via-the-p38-myc-pd-l1/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jian Wang,Ruiguang Zhang,Zhenyu Lin,Sheng Zhang,Yaobing Chen,Jing Tang,Jiaxin Hong,Xiaoshu Zhou,Yan Zong,Yingzhuo Xu,Rui Meng,Shuangbing Xu,Li Liu,Tao Zhang,Kunyu Yang,Xiaorong Dong,Gang Wu |
| Citations | 88 |
| DOI | 10.1186/s13045-020-00926-x |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://jhoonline.biomedcentral.com/counter/pdf/10.1186/s13045-020-00926-x |
| OpenAlex ID | https://openalex.org/W3043129676 |
| PMID | 32690037 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Rui Meng](https://scholariq.org/researchers/rui-meng/)

## Paper primary topic

- [Cancer-related Molecular Pathways](https://scholariq.org/topics/cancer-related-molecular-pathways/)

## Paper topics

- [Cancer-related Molecular Pathways](https://scholariq.org/topics/cancer-related-molecular-pathways/)
- [Genetics and Neurodevelopmental Disorders](https://scholariq.org/topics/genetics-and-neurodevelopmental-disorders/)
- [Epigenetics and DNA Methylation](https://scholariq.org/topics/epigenetics-and-dna-methylation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.